Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05275556 · ClinicalTrials.gov registry record · NA
Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)
A NA study, sponsored by Verily Life Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,410
- Enrollment target
NCT05275556 is a NA study that has completed, run by Verily Life Sciences. The registered enrollment target is 1,410 participants.
The verdict
NCT05275556, a NA study, has completed, sponsored by Verily Life Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,410 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, randomized controlled study to evaluate the effect of the Computer-Assisted Detection (CADe) Device on Adenomas Per Colonoscopy and Positive Percent Agreement for routine colonoscopies. The control arm is colonoscopy performed with High Definition White Light Endoscopy (HD-WLE) per standard of care. The intervention arm is colonoscopy performed with HD-WLE per standard of care plus the Computer-Assisted Detection (CADe) Device.
Interventions
- DEVICE Computer-Assisted Detection (CADe) Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,410 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2022-10-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05275556
The ClinicalTrials.gov registry entry for NCT05275556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,410 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Verily Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computer-Assisted Detection (CADe) Device is the first listed.
NCT05275556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05275556 about?
NCT05275556 is a clinical study titled "Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)". This is a prospective, multicenter, randomized controlled study to evaluate the effect of the Computer-Assisted Detection (CADe) Device on Adenomas Per Colonoscopy and Positive Percent Agreement for routine colonoscopies. The control arm is colonoscopy performed with High Definition White Light Endo...
What is the current status of trial NCT05275556?
This trial is currently completed. It is a NA study. The enrollment target is 1,410 participants. The study started on 2022-03-01. Estimated completion is 2022-10-28.
What interventions are being tested in trial NCT05275556?
The interventions under investigation include: Computer-Assisted Detection (CADe) Device (DEVICE).
Who is sponsoring clinical trial NCT05275556?
This trial is sponsored by Verily Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.